Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-31

Clinical Trial Update: Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing 3-day versus 7-day intravenous ceftriaxone prophylaxis for variceal bleeding has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Esophageal and Gastric Varices, Gastrointestinal Hemorrhage | Phase 4 | Status: COMPLETED